New version of GSP or recirculation of drug circulation

On May 30, UPS opened its new healthcare storage center in Hangzhou. This is the fourth medical health storage center newly built in Asia by UPS within two years.

The timeline chosen by this courier giant is intriguing: On June 1st, the “Pharmaceutical Business Quality Management Regulations (Revised 2012)” (referred to as the “new edition of GSP”) will be implemented. The new regulations are widely believed to reshuffle the circulation of Chinese pharmaceutical products worth more than 700 billion yuan, and also give express logistics companies the opportunity to enter the market. Not only is UPS ready to go, but companies such as TNT, Chuanhua Logistics and Shunfeng are also planning to enter the market.

According to Craig Foster, senior vice president of UPS Asia-Pacific supply chain and healthcare logistics, the establishment of the Hangzhou warehouse center is related to the growth of warehousing demand of the global medical giant Mercy East in China. Therefore, the two sides argued that this kind of "third-party logistics The "supporting" model can also be introduced in China's medical industry. It can help companies reduce the investment to establish their own distribution warehouses and reduce the cost of their supply chain.

The new version of the GSP to be implemented on June 1 puts forward higher requirements for many aspects such as drug purchase and sales channels, storage temperature and humidity control, bill management, cold chain management, and drug transportation. Including "the logistics center warehousing area of ​​not less than 10,000 square meters," and requires modern pharmaceutical logistics must first have a certain modern logistics equipment, technology and logistics management information system, can effectively integrate the upstream and downstream resources.

These stringent logistics and warehousing requirements will undoubtedly bring a big impact on the small and medium-sized pharmaceutical distribution companies. It is reported that 70% of drug distribution companies have been reshuffled out. While a large number of companies exited, they also brought opportunities to companies such as UPS and TNT.

Clegg Foster said that the Hangzhou Health Care Warehouse Center is part of the UPS global health care business growth strategy. UPS completed its first Asia-Pacific healthcare facility in Singapore in 2011 and continued to establish three new dedicated healthcare storage centers in Asia in the third quarter of 2012, located in Hangzhou, Shanghai and Australia respectively in China. Sydney. This year, UPS also announced plans to acquire a European healthcare company and expand on five health care facilities in North America.

The reason why UPS has opened two medical warehousing centers one after another in a short period of time is undoubtedly expected to grab up to 7,000-800 billion pharmaceutical circulation markets, and “the Chinese market is the fastest growing, and enough companies survive in this market. ".